Company intelligence / Profile preview

Rheumazentrum Ruhrgebiet

Herne, Nordrhein-Westfalen, Germany

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Rheumazentrum Ruhrgebiet is a leading European center for clinical care and research in rheumatology, particularly axial spondyloarthritis, participating in multi-center Phase I-IV studies and contributing significantly to translational and clinical research. It reports early and accurate diagnosis rates (>90% receiving screening within 4 weeks), provides complex rheumatological therapies, and has ongoing academic collaborations and clinical trials[2][9][12].

Therapeutic areas: ImmunologyRheumatology
Modalities: Small moleculeBiologicMonoclonal antibodyDeviceNon-pharmacological therapyVaccine
Industry: Academic Hospital/University/Research

Partnerships

Ruhr Universität BochumMulti-center academic clinical consortia

Beyond the preview

Go deeper on Rheumazentrum Ruhrgebiet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rheumazentrum Ruhrgebiet.

Explore the full profile